Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Gastrointestinal 4Gynecologic 2Tumor-Agnostic 1Other solid neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2

Interventions

Paclitaxel 74pembrolizumab 59Carboplatin 55Bevacizumab 55Specimen Handling 47Magnetic Resonance Spectroscopy 39Cisplatin 34olaparib 28Gemcitabine 26liposomal doxorubicin 24Biopsy 20Taxes 18Topotecan 17Nivolumab 17Doxorubicin 15Cyclophosphamide 15Immunoglobulin G 14Disulfides 14niraparib 12fludarabine 12Letrozole 12lenvatinib 11Surveys and Questionnaires 11atezolizumab 10Drug Therapy 10Brachytherapy 10durvalumab 9Radiotherapy 9Fulvestrant 9Docetaxel 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Genetic Testing × Gynecologic × 90 days × Clear all
NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M.D. Anderson Cancer Center

Phase NA Recruiting
1,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02664389 2026-05-06

PANEL

University Hospital, Rouen

Phase NA Terminated
289 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡